Roche initiates phase III trials for lampalizumab, first potential treatment for geographic atrophy (GA)
Roche has announced that phase III clinical studies have been initiated for lampalizumab, an investigational drug for geographic atrophy (GA), the advanced form of age-related macular degeneration...